avapritinib
illumina,blueprint medicines
['pathfinder', 'grail']
when a patient receives a cancer signal detected result from a multi-cancer early detection test, knowing the signal origin can help lead to diagnostic resolution. learn more about the new analysis from pathfinder at #asco23: 
GRAIL's mission is to detect cancer early, when it can be cured. 
Community Guidelines: https://t.co/x8f9DBN6rT 
The Cancer SIGNAL Podcast: https://t.co/6M8RXSAz8X